Close Menu

NEW YORK (GenomeWeb) – 23andMe announced today that it has partnered with Celmatix, a personalized medicine company focused on fertility and women's health, to develop and validate biomarkers to diagnose and treat infertility.

Celmatix will contribute data from its discovery and annotation of more than 5,200 genetic biomarkers related to fertility, and 23andMe will add its genetic database and research community knowledge to the collaboration.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.